CSCéline Schreiber

Céline Schreiber

*This is an algorithmically generated author record based on publicly available information.

Céline Schreiber has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Florent Moissenet

    Biomechanics and Translational Research in Surgery, Department of Surgery, University of Geneva, Geneva, Switzerland; Kinesiology Laboratory, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

    8 shared publications
  • Frédéric Dierick

    Laboratoire Forme et Fonctionnement Humain (FFH), CeREF Santé, Haute Ecole Louvain en Hainaut, Montignies-sur-Sambre, Belgium; Faculté des Sciences de la Motricité, UCLouvain, Ottignies-Louvain-la-Neuve, Belgium; RehaLAB, Centre National de Rééducation Fonctionnelle et de Réadaptation, Rehazenter, Luxembourg, Luxembourg

    7 shared publications
  • Frédéric Chantraine

    Laboratoire d’Analyse du Mouvement et de la Posture (LAMP), Centre National de Rééducation Fonctionnelle et de Réadaptation—Rehazenter, Rue André Vésale 1, 2674 Luxembourg, Luxembourg

    6 shared publications
  • Frédéric Chantraine

    CNRFR - Rehazenter, Laboratoire d'Analyse du Mouvement et de la Posture, Luxembourg, Luxembourg

    5 shared publications
  • Gilles Areno

    RehaLAB, Centre National de Rééducation Fonctionnelle et de Réadaptation—Rehazenter, Rue André Vésale 1, 2674 Luxembourg, Luxembourg

    5 shared publications
  • José Alexandre Pereira

    Medical Department, Centre National de Rééducation Fonctionnelle et de Réadaptation—Rehazenter, Rue André Vésale 1, 2674 Luxembourg, Luxembourg

    5 shared publications

Latest Publications

  • Open Access

    Upper-Limb Cryoneurolysis for Painful Post-Stroke Spasticity in Severely Impaired Upper Limbs: A Feasibility Case Series

    by José Alexandre Pereira, Frédéric Chantraine, Céline Schreiber, Tanja Classen, Evangelia Agneskis, Laurence Medinger, Silvia Morini, Gilles Areno, Xavier Masson, Frédéric Dierick

    Background: Post-stroke upper-limb spasticity can cause pain, hinder passive care, and lead to secondary musculoskeletal complications. Current minimally invasive treatments have important limitations. Cryoneurolysis, which creates a controlled cold lesion of peripheral nerves, may offer a partially reversible focal denervation alternative. Methods: We conducted a feasibility case series in the outpatient department of a rehabilitation centre. Three adults with chronic post-stroke hemiparesis and a non-functional spastic upper limb underwent ultrasound- and nerve stimulation-guided cryoneurolysis of the musculocutaneous, median, and/or ulnar nerves. All had demonstrated a positive response to diagnostic nerve blocks beforehand. Feasibility outcomes included completion of planned nerve targets, tolerability under local anesthesia, absence of serious adverse events, and completion of 6-month follow-up. Secondary outcomes were Modified Ashworth Scale (MAS), qualitatively assessed passive joint mobility (video-documented), pain measured by visual analogue scale, sensory testing, and electroneuromyography (ENMG). Results: All procedures were completed as planned. Treatment was well tolerated under local anesthesia, and no serious adverse events occurred. MAS decreased by at least 2 points in targeted patterns, with immediate improvement in passive mobility; these effects persisted at 6 months. Pain remained unchanged in two participants and improved in one. Sensory testing at 6 weeks was stable. ENMG findings were heterogeneous, including reduced ulnar sensory action potential amplitude and biceps denervation activity in one participant. Conclusions: In this small series, cryoneurolysis for post-stroke upper-limb spasticity was feasible and associated with sustained tone reduction and improved passive mobility. Larger controlled studies are required to better define safety, optimize targeting strategies, and assess patient-centred outcomes.


  • Open Access

    Upper Limb Cryoneurolysis for Painful Post-Stroke Spasticity in Severely Impaired Upper Limbs: A Feasibility Case Series

    by José Alexandre Pereira, Fréderic Chantraine, Céline Schreiber, Tanja Classen, Evangelia Agneskis, Laurence Medinger, Silvia Morini, Gilles Areno, Xavier Masson, Frederic Dierick

    Background: Post-stroke upper-limb spasticity can cause pain, hinder passive care, and lead to secondary musculoskeletal complications. Current minimally invasive treatments have important limitations. Cryoneurolysis, which creates a controlled cold lesion of peripheral nerves, may offer a partially reversible focal denervation alternative. Methods: We conducted a feasibility case series in the outpatient department of a rehabilitation center. Three adults with chronic post-stroke hemi-paresis and a non-functional spastic upper limb underwent ultrasound- and nerve stimula-tion-guided cryoneurolysis of the musculocutaneous, median, and/or ulnar nerves. All had demonstrated a positive response to diagnostic nerve blocks beforehand. Feasibility outcomes in-cluded completion of planned nerve targets, tolerability under local anesthesia, absence of serious adverse events, and completion of 6-month follow-up. Secondary outcomes were Modified Ash-worth Scale (MAS), qualitatively assessed passive joint mobility (video-documented), pain meas-ured by visual analogue scale, sensory testing, and electroneuromyography (ENMG). Results: All procedures were completed as planned. Treatment was well tolerated under local anesthesia, and no serious adverse events occurred. MAS decreased by at least 2 points in targeted patterns, with immediate improvement in passive mobility; these effects persisted at 6 months. Pain remained unchanged in two participants and improved in one. Sensory testing at 6 weeks was stable. ENMG findings were heterogeneous, including reduced ulnar sensory action potential amplitude and biceps denervation activity in one participant. Conclusions: In this small series, cryoneurolysis for post-stroke upper-limb spasticity was feasible and associated with sustained tone reduction and improved passive mobility. Larger controlled studies are required to better define safety, optimize targeting strategies, and assess patient-centered outcomes.

  • Open Access

    Targeted and Sequential Cryoneurolysis Improves Gait After Botulinum-Toxin Unresponsiveness in Post-Stroke Spasticity: A Laboratory-Verified Case

    by Frédéric Chantraine, José Alexandre Pereira, Céline Schreiber, Tanja Classen, Gilles Areno, Frédéric Dierick

    Background: Chronic post-stroke spasticity often limits gait despite best-practice botulinum-toxin intramuscular injections (BTIs), whose benefit is constrained by short duration, dose ceilings, and tachyphylaxis. Cryoneurolysis (CNL) induces a reversible axonotmesis with preserved endoneurium, potentially providing longer tone reduction with fewer adverse effects, but its impact on whole-gait quality and its compatibility with implanted functional electrical stimulation (FES) remain poorly documented. Case presentation: A 43-year-old man, 12 years after right middle cerebral artery stroke, walked independently with an implanted common peroneal FES system but complained of effortful gait with left-knee “locking” and drop foot without FES. Multiple BTI series to triceps surae and quadriceps yielded only transient benefit. Two ultrasound-guided CNL sessions targeted tibial (soleus, medial gastrocnemius) and femoral (rectus femoris, vastus intermedius) motor branches. Quantitative gait analysis and fine-wire electromyography (EMG) were performed at baseline, 6 weeks after each CNL, and at 6 months, with and without FES. CNL produced immediate and sustained reductions in triceps surae and quadriceps overactivity, resolution of genu recurvatum, normalization of stiff-knee gait, improved ankle dorsiflexion, and increased swing phase knee flexion (>50°). Gait Deviation Index rose from 69 to 80 and Gillette Gait Index decreased by more than 50%, with preserved strength and without adverse events. Conclusions: Targeted, sequential CNL of tibial and femoral motor branches can safely deliver durable, clinically meaningful gait improvements when BTI has reached its ceiling and can act synergistically with implanted FES. Quantitative gait analysis and EMG sharpen clinical decision-making in spasticity management.


  • Open Access

    Targeted and Sequential Cryoneurolysis Improves Gait After Botulinum-Toxin Unresponsiveness in Post-Stroke Spasticity: A Laboratory-Verified Case

    by Frédéric Chantraine, José Alexandre Carvalho Pereira, Céline Schreiber, Tanja Classen, Gilles Areno, Frederic Dierick

    Background Chronic post-stroke spasticity often limits gait despite best-practice botulinum-toxin intramuscular injections (BTI), whose benefit is constrained by short duration, dose ceilings and tachyphylaxis. Cryoneurolysis (CNL) induces a reversible axonotmesis with preserved endoneurium, potentially providing longer tone reduction with fewer adverse effects, but its impact on whole-gait quality and its compatibility with implanted functional electrical stimulation (FES) remain poorly documented. Case presentation A 43-year-old man, 12 years after right middle cerebral artery stroke, walked independently with an implanted common peroneal FES system but complained of effortful gait with left-knee “locking” and drop foot without FES. Multiple BTI series to triceps surae and quadriceps yielded only transient benefit. Two ultrasound-guided CNL sessions targeted tibial (soleus, medial gastrocnemius) and femoral (rectus femoris, vastus intermedius) motor branches. Quantitative gait analysis and fine-wire electromyography (EMG) were performed at baseline, 6 weeks after each CNL, and 6 months, with and without FES. CNL produced immediate and sustained reductions in triceps surae and quadriceps overactivity, resolution of genu recurvatum, normalization of stiff-knee gait, improved ankle dorsiflexion, and increased swing-phase knee flexion (>50°). Gait Deviation Index rose from 69 to 80 and Gillette Gait Index decreased by more than 50%, with preserved strength and no adverse events. Conclusions Targeted, sequential CNL of tibial and femoral motor branches can safely deliver durable, clinically meaningful gait improvements when BTI has reached its ceiling and can act synergistically with implanted FES. Quantitative gait analysis and EMG sharpen clinical decision-making in spasticity management.

  • Open Access

    CHECGAIT: A Functional Electrical Stimulation Clinical Pathway to Reduce Foot Drop during Walking in Adult Patients with Upper Motor Neuron Lesions

    by Gilles Areno, Frédéric Chantraine, Céline Schreiber, Xavier Masson, Tanja Classen, José Alexandre Carvalho Pereira, Frédéric Dierick

    Foot drop during the swing phase of gait and at initial foot contact is a current kinematic abnormality that can occur following an upper motor neuron (UMN) lesion. Functional electrical stimulation (FES) of the common peroneal nerve through an assistive device is often used in neuro-rehabilitation to help patients regain mobility. Although there are FES-specific guideline recommendations, it remains a challenge for clinicians to appropriately select patients eligible for the daily use of FES devices, as very few health insurance systems cover its cost in Europe. In Luxembourg, since 2018, successfully completing an FES clinical pathway called CHECGAIT is a prerequisite to receiving financial coverage for FES devices from the national health fund (Caisse Nationale de Santé—CNS). This study describes the structure and steps of CHECGAIT and reports our experience with a cohort of 100 patients enrolled over a three-year period. The clinical and gait outcomes of all patients were retrospectively quantified, and a specific analysis was performed to highlight differences between patients with and without an FES device prescription at the end of a CHECGAIT. Several significant gait differences were found between these groups. These results and CHECGAIT may help clinicians to better select patients who can most benefit from this technology in their daily lives. In addition, CHECGAIT could provide significant savings to public health systems by avoiding unnecessary deliveries of FES devices.


  • Open Access

    Classification of Stiff-Knee Gait Kinematic Severity after Stroke Using Retrospective k-Means Clustering Algorithm

    by Frédéric Chantraine, Céline Schreiber, José Alexandre Carvalho Pereira, Jérôme Kaps, Frédéric Dierick

    Nowadays, a classification system for unilateral stiff-knee gait (SKG) kinematic severity in hemiparetic adult patients after stroke does not exist. However, such classification would be useful to the clinicians. We proposed the use of the k-means method in order to define unilateral SKG severity clusters in hemiparetic adults after stroke. A retrospective k-means cluster analysis was applied to five selected knee kinematic parameters collected during gait in 96 hemiparetic adults and 19 healthy adults from our clinical gait analysis database. A total of five discrete knee kinematic clusters were determined. Three clusters of SKG were identified, based on which a three-level severity classification was defined: unbend-knee gait, braked-knee gait, and frozen-limb gait. Preliminary construct validity of the classification was obtained. All selected knee kinematic parameters defining the five clusters and the majority of usual kinematic parameters of the lower limbs showed statistically significant differences between the different clusters. We recommend diagnosing SKG for values strictly below 40° of knee flexion during the swing phase. Clinicians and researchers are now able to specify the level of kinematic severity of SKG in order to optimize treatment choices and future clinical trial eligibility criteria.


  • Neuroplastic changes mediate motor recovery with implanted peroneal nerve stimulator in individuals with chronic stroke: An open-label multimodal pilot study

    by Aurore Thibaut, Carol Di Perri, Lizette Heine, Florent Moissenet, Frederic Chantraine, Céline Schreiber, Paul Filipetti, Charlotte Martial, Jitka Annen, Steven Laureys, et al.


  • Open Access

    Asymptomatic Genu Recurvatum Reshapes Lower Limb Sagittal Joint and Elevation Angles During Gait at Different Speeds

    by Frédéric Dierick, Céline Schreiber, Pauline Lavallée, Fabien Buisseret

    Purpose: The main objective of this study is to characterize the lower limb sagittal joint and elevation angles during walking in participants with asymptomatic genu recurvatum and compare it with control participants without knee deformation. The secondary objective is to study the influence of walking speed on these kinematic variables. Methods: The spatio-temporal parameters and kinematics of the lower limb were recorded using an optoelectronic motion capture system in 26 partici-pants ( n = 13 with genu recurvatum and n = 13 controls). The participants walked on an instrumented treadmill during five minutes at three different speeds: slow, medium and fast. Results: Participants with genu recurvatum showed several significant differences with controls: a narrower step width, a greater maximum hip joint extension angle, a greater knee joint extension angle at mid stance, a lower maximum knee joint flexion angle during the swing phase, and a greater ankle joint extension angle at the end of the gait cycle. Participants with genu recurvatum had a greater minimum thigh elevation angle, a greater maximum foot elevation angle, and a change in the orientation of the covariance plane. Walking speed had a significant effect on nearly all lower limb joint, elevation angle, and covariance plane parameters. Conclusion: Our findings show that genu recurvatum reshapes lower limb sagittal joint and elevation angles during walking at different speeds but preserves the covariation of elevation angles along a plane during both stance and swing phases and the rotation of this plane with increasing speed.

  • Open Access

    A multimodal dataset of human gait at different walking speeds established on injury-free adult participants

    by Céline Schreiber, Florent Moissenet

    Human motion capture is used in various fields to analyse, understand and reproduce the diversity of movements that are required during daily-life activities. The proposed dataset of human gait has been established on 50 adults healthy and injury-free for lower and upper extremities in the most recent six months, with no lower and upper extremity surgery in the last two years. Participants were asked to walk on a straight level walkway at 5 speeds during one unique session: 0–0.4 m.s−1, 0.4–0.8 m.s−1, 0.8–1.2 m.s−1, self-selected spontaneous and fast speeds. Three dimensional trajectories of 52 reflective markers spread over the whole body, 3D ground reaction forces and moment, and electromyographic signals were simultaneously recorded. For each participants, a minimum of 3 trials per condition have been made available in the dataset for a total of 1143 trials. This dataset could increase the sample size of similar datasets, lead to analyse the effect of walking speed on gait or conduct unusual analysis of gait thanks to the full body markerset used.